New Study Links Ozempic to Vision Loss, Confirms Harvard Research
Another study has been published suggesting that patients taking semaglutide—the active ingredient in Novo Nordisk’s blockbuster drug Ozempic—may face a higher risk of developing a rare eye condition that can lead to...
Read More